Defence, Security, Energy, Utilities, Finance, Pharmaceuticals
Home > Pharmaceuticals > UK

Superbugs & Superdrugs - Pushing financial incentives and collaborative incentives to accelerate clinical success

16th March to 17th March 2016, London, United Kingdom



The threat of antibiotic- resistant microbes poses one of the biggest economic and health threats in our time, as microbes are becoming more resistant and fewer drugs are passing clinical trials successfully.

Moreover, the increase in global migration accelerates the spread as we have seen from Mers and Ebola viruses, as well as overconsumption and hospital acquired infections.

Thus, our 18th year in hosting Superbugs and Superdrugs continues to address the core challenges in the industry from: Investment, R&D to hospital hygiene, and consumer engagement and review current strategies.

We’re now seeing strong leaderships and collaborations to fund research and investment from the likes of: The Welcome Trust, IMI, and BARDA who are invited to share their funding strategies to strengthen the antiobiotics pipeline.

Benefits of Attending


Featured Speakers


Who Should Attend